Thalys Medical Technology Group Inc.

Shanghai Stock Exchange 603716.SS

Thalys Medical Technology Group Inc. Net Cash Used For Investing Activities for the year ending December 31, 2023: USD 2.14 M

Thalys Medical Technology Group Inc. Net Cash Used For Investing Activities is USD 2.14 M for the year ending December 31, 2023, a -90.75% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.

Thalys Medical Technology Group Inc. Net Cash Used For Investing Activities for the year ending December 31, 2022 was USD 23.14 M, a 228.19% change year over year.
Thalys Medical Technology Group Inc. Net Cash Used For Investing Activities for the year ending December 31, 2021 was USD -18.05 M, a 59.22% change year over year.
Thalys Medical Technology Group Inc. Net Cash Used For Investing Activities for the year ending December 31, 2020 was USD -44.27 M, a -9.17% change year over year.
Thalys Medical Technology Group Inc. Net Cash Used For Investing Activities for the year ending December 31, 2019 was USD -40.55 M, a -21.90% change year over year.

Key data

Date	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure

Shanghai Stock Exchange: 603716.SS

Thalys Medical Technology Group Inc.

CEO	Mr. Zheng Wang
IPO Date	Oct. 31, 2016
Location	China
Headquarters	1310 Jinshan Avenue
Employees	1,406
Sector	Health Care
Industries Pharmaceuticals Hospitals & Clinics

Description

Thalys Medical Technology Group Inc. engages in the medical intensive business and operation services in China. The company was formerly known as Thalys Medical Technology Inc. and changed its name to Thalys Medical Technology Group Inc. in September 2020. Thalys Medical Technology Group Inc. was founded in 2004 and is headquartered in Wuhan, China.

Key trends

Past 5 years